Immune-associated plasma proteins in oral and oropharyngeal cancer patients-Reference-Cited by-同舟云学术

Immune-associated plasma proteins in oral and oropharyngeal cancer patients

Published:2022-09 Issue:9 Volume:8 Page:e10753
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Buranapraditkun Supranee,Mahattanasakul Patnarin,Diloktaweewattana Areeya,Bhummaphan Narumol,Siriwattanakankul Chutha^ORCID,Bin-Alee Fardeela,Tangjaturonrasme Napadon^ORCID,Mutirangura Apiwat,Kitkumthorn Nakarin^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference26 articles.

1. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases;Arduino;J. Oral Maxillofac. Surg.,2008

2. Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma;Chang;Otolaryngol. Head Neck Surg.,2013

3. Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma;Cheng;PLoS One,2014

4. Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies;Chester;Blood,2018

5. High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis;Finkelmeier;Eur. J. Cancer,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal inference of the effect of plasma proteins on the incidence of oral cancer: two-sample Mendelian randomization;BMC Oral Health;2024-09-08

2. High 4-1BB Expression in PBMCs and Tumor Infiltrating Lymphocytes (TILs) in Patients with Head and Neck Squamous Cell Carcinoma;European Journal of Dentistry;2023-05-02